insights_auto
Why is NEO up २.१२%?
Dive Deeperchevron_right
NEO:NASDAQ
NeoGenomics, Inc.
US$ १६.८४
arrow_upward
+२.१२%(+०.३५) 1D
US$ १६.८४
०.००% (०.००)
bedtimeAfter hours
Closed: नोभेम्बर ६, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NEO...
Open
US$ १६.८५
High
US$ १६.९३
Low
US$ १६.१२
Mkt. cap
२.१८ अरब
Avg. vol.
२१.२१ लाख
Volume
१३.१४ लाख
52-wk high
US$ २०.१५
52-wk low
US$ ७.०६
EPS
-US$ ०.२५
Beta
१.८७
Shares outstanding
१२.९४ करोड
No. of employees
२ हजार
Open
US$ १६.८५
High
US$ १६.९३
Low
US$ १६.१२
Mkt. cap
२.१८ अरब
Avg. vol.
२१.२१ लाख
Volume
१३.१४ लाख
52-wk high
US$ २०.१५
52-wk low
US$ ७.०६
EPS
-US$ ०.२५
Beta
१.८७
Shares outstanding
१२.९४ करोड
No. of employees
२ हजार
News stories
From web sources and news partners
Yahoo Finance
·
२ दिन पहिले
Did Narrower Quarterly Loss Just Shift NeoGenomics Stock Investment Narrative?
Profile
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas. Wikipedia
About NeoGenomics, Inc.
CEOChristopher M. Smith
Employees२.५ हजार
Founded२००२
Headquartersफोर्ट मायर्स, फ्लोरिडा, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websiteneogenomics.com